Vaccine News and Research

Latest Vaccine News and Research

Epimmune presents SIV vaccine study data showing control of virus despite the presence of viral mutations

Epimmune today presented preliminary data from its ongoing SIV rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland.

31 Aug 2004

Major trends in AIDS research that the different research teams throughout the world are pursuing

The science will be presented during the conference which is taking place in Lausanne until September 1, 2004. The advances in fundamental research, notably through a better understanding of the complex processes of immune defence, HIV and the functioning of vaccines, promote the genesis and development of new vaccine candidates.

30 Aug 2004

Interim data from human clinical trials of two AIDS vaccine candidates, named DNA.HIVA and MVA.HIVA

The interim data, from 205 volunteers in clinical trials in Kenya, Uganda and the United Kingdom, show that DNA.HIVA and MVA.HIVA are generally safe and well tolerated. However, the candidates’ ability to elicit an anti-HIV cell-mediated immune response is poor, using currently accepted measures of immune response.

30 Aug 2004

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

At the opening ceremony of the Lausanne, Switzerland, AIDS VACCINE '04 conference, leaders in the field of AIDS vaccine research called for increased political and financial commitment to facilitate the development of preventive and therapeutic AIDS vaccines as a public health imperative in fighting HIV/AIDS.

30 Aug 2004

Rabies case in South-West France

The Health Protection Agency has today become aware of a case of confirmed rabies, diagnosed in a dog in South-West France. The dog, which has died, had been imported illegally into the European Union through Spain from Morocco and then onto France.

29 Aug 2004

U.S. plan for influenza pandemic response

The U.S. Department of Health & Human Services has unveiled the draft Pandemic Influenza Response and Preparedness Plan, which outlines a coordinated national strategy to prepare for and respond to an influenza pandemic.

26 Aug 2004

Chiron delays Fluvirin influenza virus vaccine shipments

Chiron has announced that, in conducting final internal release procedures for its Fluvirin(R) influenza virus vaccine, the company's quality systems have identified a small number of lots that do not meet product sterility specifications.

26 Aug 2004

Powdered form of anthrax vaccine could eliminate needle injections

Researchers have developed a powdered form of an anthrax vaccine that could potentially be inhaled through the nose and eliminate the need for needle injections.

26 Aug 2004

West Nile Virus found in Alberta

Alberta's first West Nile virus positive bird of the 2004 season has been detected in Lethbridge. A mosquito pool and a horse in Southern Alberta have also tested positive for the virus.

25 Aug 2004

High-resolution images reveal the molecular rearrangements that rotavirus uses to break into cells

High-resolution images constructed by researchers at Children's Hospital Boston and Harvard Medical School reveal the molecular rearrangements that rotavirus – the most common cause of severe, dehydrating diarrhea and vomiting in children worldwide – uses to break into cells.

25 Aug 2004

Australian research giant begins trial of avian influenza vaccine

The trial vaccine utilises Imugene Limited's platform adenoviral vector technology to deliver the necessary genetic material to stimulate the birds' immune responses.

25 Aug 2004

Regular exercise boosts immune system in older men

As it turns out, judging by the reaction strength of their immune system to an unknown, but harmless, protein antigen, it’s possible for men over 70 to mount an immune response similar to that produced by much younger men -- if they get regular moderate physical activity of about six hours a week.

25 Aug 2004

Exposure to simian virus 40 (SV40) is not associated with cancer in humans

Two upcoming studies by scientists at the National Cancer Institute (NCI), provide further evidence that exposure to simian virus 40 (SV40) is not associated with cancer in humans.

23 Aug 2004

Diarrhea the leading cause of death among the developing world's children

To most people in the developed world, diarrhea is a nuisance. It means some discomfort and maybe a trip to the local pharmacy.

23 Aug 2004

Surprise finding could lead to hepatitis C vaccine

New research from the University of New South Wales shows some people may repeatedly be able to clear hepatitis C virus from their bodies, without any biological traces of the potentially serious infection.

23 Aug 2004

Development of plant-derived topical medications to prevent HIV/AIDS and other STD's

Researchers at the Biodesign Institute at ASU have been tapped to lead development of plant-derived topical medications that would prevent HIV/AIDS and other sexually-transmitted diseases.

21 Aug 2004

Manitoba's first human case of West Nile virus infection

The first human case of West Nile virus infection this year has been identified in Manitoba. The individual, a Winnipeg resident in his sixties, is currently in hospital. The individual has been reported to Health Canada as a probable case of West Nile neurological syndrome.

20 Aug 2004

First probable human case of West Nile virus infection in Indiana

Indianpolis State health officials report that a Benton County resident is the first probable human case of West Nile virus infection in Indiana this year.

20 Aug 2004

Five-in-one vaccine is an important step forward in the UK's vaccination programme

The new five-in-one vaccine is an important step forward in the United Kingdom's vaccination programme, say child health experts in this week's BMJ.

20 Aug 2004

2004 AIDS Vaccine Conference has announced it's forthcoming programme

The Conference will examine the entire spectrum of issues in AIDS vaccine development and deployment, including the global effort in preventative and therapeutic vaccines, immunology, pediatric and adolescent vaccines, clinical trials in emerging countries and the need for strong political and financial commitment.

17 Aug 2004